Financial News Feed

Weaker Buy Today ABEO ranks #611 as BUY CANDIDATE. Stronger Buy
Today ABEO ranks #611 as BUY CANDIDATE.

ABEO stock Abeona Therapeutics Inc.

ABEO stock
Abeona Therapeutics Inc.

Looking at the recent signals on shares of Abeona Therapeutics (ABEO), we can see that the short-term MACD indicator is presently pointing to a Buy. The MACD is typically used to measure bullish or be...

Read more

Abeona Therapeutics Inc. (NASDAQ:ABEO) has been in the news after the price of the stock hit $7.86 at the conclusion of the most recent close. The stock is traded on NSDQ in the Medical sector and Med...

Read more

Both DBV Technologies S.A. (NASDAQ:DBVT) and Abeona Therapeutics Inc. (NASDAQ:ABEO) are each other’s competitor in the Biotechnology industry. Thus the compare...

Read more

Jaguar Health Inc. (NASDAQ:JAGX) and Abeona Therapeutics Inc. (NASDAQ:ABEO), both competing one another are Biotechnology companies. We will contrast their analyst recommendations, profitability, inst...

Read more

The stock of Abeona Therapeutics Inc. (NASDAQ:ABEO) is a huge mover today! The stock increased 4.58% or $0.36 during the last trading session, reaching $8.22. About 280,213 shares traded. Abeona Thera...

Read more

The stock of Abeona Therapeutics Inc. (NASDAQ:ABEO) is a huge mover today! The stock increased 4.20% or $0.33 during the last trading session, reaching $8.19. About 252,556 shares traded. Abeona Thera...

Read more

Abeona Therapeutics Inc. (NASDAQ:ABEO) increased to $8.23. It was reported on Mar, 21 according to Barchart.com. Abeona Therapeutics Inc. (NASDAQ:ABEO) has...

Read more

At the time of writing, Green REIT plc (ISE:GN1) has a Piotroski F-Score of 5. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak pe...

Read more

Brokerages expect Abeona Therapeutics Inc (NASDAQ:ABEO) to post $2.50 million in sales for the current quarter, according to Zacks. Two analysts have provided estimates for Abeona Therapeutics’ earn...

Read more

The EBITDA Yield is a great way to determine a company’s profitability. This number is calculated by dividing a company’s earnings before interest, taxes, depreciation and amortization by the comp...

Read more

Analysts expect Abeona Therapeutics Inc (NASDAQ:ABEO) to post $2.50 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Abeona Therap...

Read more

CEL-SCI Corporation (NYSEAMERICAN:CVM) and Abeona Therapeutics Inc. (NASDAQ:ABEO) compete with each other in the Biotechnology sector. We will analyze and contrast their dividends, institutional owner...

Read more

We are contrasting Geron Corporation (NASDAQ:GERN) and Abeona Therapeutics Inc. (NASDAQ:ABEO) on their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and va...

Read more

Active investors might be watching some signal indicators on shares of Abeona Therapeutics (ABEO). Recently, we have noted that the 100-day moving average verse price signal as Buy. This is the signal...

Read more

Abeona Therapeutics (ABEO) shares are showing bullish signs as the Chaikin Money Flow or CFI is above the zero line. A positive Chaikin Money Flow indicates that the stock is strong while a negative C...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank